Taken together, our study will provide vital theoretical evidence for explaining the mechanisms of lncRNA DLEU2/miR-30c-5p/SOX9 axis in NSCLC, and at the same time will provide new biomarker and target for the diagnosis and treatment of NSCLC. The gene discussed is SOX9; the disease is non-small cell lung carcinoma.